Cost-effectiveness of a 12-month fixed-duration venetoclax treatment in combination with obinutuzumab in first-line, unfit chronic lymphocytic leukemia in the United States

by Chatterjee, A., Davids, M.S, Manzoor, B.S, Qendri, V., Ravelo, A., Sail, K., Shapouri, S., van de Wetering, G.
Published 2021

Economic and clinical outcomes of pegfilgrastim via prefilled syringe vs on-body injector: A real-world data analysis

by Campbell, D., Campbell, K., Li, E., McBride, A., Schroader, B., Wang, W.
Published 2021

The Effect of Repeated abobotulinumtoxinA (Dysport®) Injections on Walking Velocity in Persons with Spastic Hemiparesis Caused by Stroke or Traumatic Brain Injury

by Brashear, A., Deltombe, T., Esquenazi, A., Gracies, J.-M, Grandoulier, A.-S, Krawczyk, M., O'Dell, M.W, Picaut, P., Rudzinska-Bar, M., Skoromets, A., Vilain, C.
Published 2021

Continuous, objective measurement of physical activity during chemotherapy for breast cancer: The Activity in Treatment pilot study

by Hartman, S.J, Natarajan, L., Nelson, S.H, Parker, B.A, Patterson, R.E, Weiner, L.S
Published 2021

Serum thymidine kinase activity in patients with hormone receptor-positive and HER2-negative metastatic breast cancer treated with palbociclib and fulvestrant

by Ballestrero, A., Benelli, M., Bergqvist, M., Bernardo, A., Bliss, J.M, Bonetti, A., Breast International Group and PYTHIA Collaborators, Cameron, D., Colleoni, M., Davies, D.M, De Swert, H., Duhoux, F.P, Fumagalli, D., Gebhart, G., Henry, S., Hilbers, F.S, Ignatiadis, M., International Breast Cancer Study Group, Jerusalem, G., Kammler, R., Loi, S., MacPherson, I.R, Maibach, R., Malorni, L., McCartney, A., Migliaccio, I., Neven, P., Papadimitriou, K., Piccart, M., Regan, M.M, Ruepp, B., Seles, E., Thomson, A., Tyekucheva, S., Zoppoli, G.
Published 2022

Psychotic Symptoms as the Initial Presentation of a Long-Lasting Misdiagnosed Anti-GAD65 Autoimmune Encephalitis: An Emblematic Case and Literature Review

by Cai, D., Gong, S., Huang, B., Kong, F., Li, J., Lin, S., Wang, J., Zhang, T., Zheng, H.
Published 2022

Cost-effectiveness of ribociclib plus endocrine therapy versus placebo plus endocrine therapy in HR-positive, HER2-negative breast cancer

by Hays, E., Le, V., Narsipur, N., Rosario, K., Tran, D.K, Wilson, L., Zhong, L.
Published 2021

The potential therapeutic role of PTR1 gene in non-healing anthroponotic cutaneous leishmaniasis due to Leishmania tropica

by Bamorovat, M., Davoudi, N., Ghasemi Nejad Almani, P., Kazemi, B., Khosravi, A., Salari, S., Salarkia, E., Sezavar, M., Sharifi, I.
Published 2021

Impact of cyclic changes in pharmacokinetics and absorbed dose in pediatric neuroblastoma patients receiving [177Lu]Lu-DOTATATE

by Aldridge, M.D, Falzone, N., Gains, J.E, Gaze, M.N, Lee, B.Q, Malcolm, J.C, Mirando, D., Vallis, K.A
Published 2022

Extra-anatomic percutaneous stenting of a malignant afferent loop obstruction following pancreaticoduodenectomy

by Fotheringham, T., Hutchins, R., Khan, S., Lam, S.
Published 2022

Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy

by Andreatta, M., Barras, D., Benedetti, F., Berthold, D.R, Bourhis, J., Carmona, S.J, Corria-Osorio, J., Coukos, G., Crespo, I., Dafni, U., de Olza, M.O, Dimopoulou, G., Dromain, C., Duran, R., Foukas, P., Genolet, R., Ghisoni, E., Harari, A., Herrera, F.G, Imbimbo, M., Irving, M., Kandalaft, L.E, Laniti, D.D, Messemaker, M., Orcurto, A., Pittet, M.J, Prior, J., Rodrigo, B.N, Ronet, C., Rusakiewicz, S., Sarivalasis, A., Schaefer, N., Sempoux, C., Smith, T., Spill, A., Tsourti, Z., Warren, S.E, Zaman, K., Zimmermann, S.
Published 2022

Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide-pretreated myeloma: A subanalysis of OPTIMISMM by clinical characteristics

by Anderson, L.D., Jr, Beksac, M., Corso, A., Dimopoulos, M., Dürig, J., Engelhardt, M., Galli, M., Grote, L., Jenner, M., Jiang, R., Kanate, A.S, Larocca, A., Liberati, A.M, Lindsay, J., Moreau, P., Oriol, A., Pavic, M., Peluso, T., Richardson, P.G, Robak, P., Rodriguez-Otero, P., Salomo, M., Schjesvold, F., Sonneveld, P., Vural, F., Weisel, K., White, D., Yagci, M.
Published 2022

A Phase 2 Trial Combining Pembrolizumab and Palliative Radiation Therapy in Gastroesophageal Cancer to Augment Abscopal Immune Responses

by Chao, J., Chen, H., Chen, Y.-J, D'Apuzzo, M., Fakih, M., Frankel, P., He, T.-F, Klempner, S.J, Lee, P., Solomon, S., Tajon, M.
Published 2022

ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition

by Abla, O., Alexandrescu, S., Allotey, J., Atkinson, M., Barbaro, P.M, Baykov, V.V, Beilken, A., Bonneau-Lagacherie, J., Bornemann, A., Brandt, J.M, Collin, M., Dembowska-Baginska, B., Diamond, E.L, Donadieu, J., Durham, B.H, Ebinger, M., El Demellawy, D., Eldem, I., Emile, J.-F, Empringham, B., Ernestus, K., Evseev, D.A, Farnault, L., Fend, F., Feuerhake, F., Flucke, U.E, Fraitag, S., Garg, S., Gaspari, S., Gessi, M., Grier, D.D, Gryniewicz-Kwiatkowska, O., Haroche, J., Hélias-Rodzewicz, Z., Henry, M.M, Héritier, S., Hiemcke-Jiwa, L., Hogendoorn, P.C.W, Hornick, J.L, Jullié, M.-L, Kemps, P.G, Kumar, A.R, Lamaison, C., Leino, D.G, Lorsbach, R., Madni, M., Massoth, L.R, Méry, T., Möhle, R., Muñoz-Arcos, L.S, Peeke, S.Z, Petrova-Drus, K., Picarsic, J., Picton, S., Potapenko, V., Poulin, A., Raghunathan, A., Rossi, S., Roy, S., Schafernak, K.T, Sciot, R., Sisk, B.A, Sridhar, V., Suchi, M., Swanson, A.A, Tam, I.S, Tamburrini, G., Tiwari, N., Turner, K., van de Wetering, M.D, van den Bos, C., van Halteren, A.G.S, van Laar, J.A.M, van Noesel, C.J.M, Verdijk, R.M, Weinstein, J.L, Whitlock, J.A, Wiegering, V., Woei-A-Jin, F.J.S.H, Yaseen, N.R, Yeo, K.K
Published 2022

Hematologic complications with age in Shwachman-Diamond syndrome

by Bertuch, A.A, Davies, S.M, Fleming, M.D, Furutani, E., Galvin, A., Gansner, J.M, Geddis, A.E, Hanna, R., Keel, S.B, Larson, J.H, Lau, B.W, Lipton, J.M, Liu, S., Lorsbach, R., Loveless, S.K, Malsch, M.M, Mount, L., Myers, K.C, Nakano, T.A, Queenan, K., Shimamura, A., Steltz, S., Vlachos, A., Wang, W.C, Weller, E.
Published 2022

Phase Ib Study of the Histone Deacetylase 6 Inhibitor Citarinostat in Combination With Paclitaxel in Patients With Advanced Solid Tumors

by Connarn, J.N, Dumitru, C.D, Gordon, M.S, Harvey, R.D, Juric, D., Le Bruchec, Y., Lu, B., Sarantopoulos, J., Shapiro, G.I, Zarotiadou, A.
Published 2022

Impact of fatigue on quality of life among breast cancer patients receiving chemotherapy

by Karuppannan, M., Mohammed, A.H, Muthanna, F.M.S, Rasool Hassan, B.A
Published 2021

Lung transplant recipients receiving voriconazole and skin squamous cell carcinoma risk in Australia

by Kong, D.C.M, Kotsimbos, T., Levvey, B., Morrissey, O., Neoh, C.F, Slavin, M.A, Snell, G.I, Stewart, K.
Published 2014

Meiotic susceptibility for induction of sperm with chromosomal aberrations in patients receiving combination chemotherapy for Hodgkin lymphoma

by Frias, S., Meistrich, M.L, Van Hummelen, P., Wyrobek, A.J
Published 2021

A phase I trial adding poly(ADP-ribose) polymerase inhibitor veliparib to induction carboplatin-paclitaxel in patients with head and neck squamous cell carcinoma: Alliance A091101

by de Souza, J.A, Foster, N.R, Jelinek, M.J, Munster, P.N, Schwartz, G.K, Seiwert, T.Y, Vokes, E.E, Zoroufy, A.J
Published 2021